您的位置: 首页 > 农业专利 > 详情页

Pro drug form (p2pdox) of the highly potent 2 pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
专利权人:
发明人:
GOVINDAN SERENGULAM V,MCBRIDE WILLIAM J,SATHYANARAYAN NALINI,MAZZA-FERREIRA CHRISTINE,GOLDENBERG DAVID M
申请号:
IN4079/DELNP/2015
公开号:
IN2015DN04079A
申请日:
2015.05.13
申请国别(地区):
IN
年份:
2016
代理人:
摘要:
Disclosed are methods compositions and uses of conjugates of prodrug forms of 2 pyrrolinodoxorubicin (P2PDox) with antibodies or antigen binding fragments thereof (ADCs) with targetable construct peptides or with other targeting molecules that are capable of delivering the P2PDox to a targeted cell tissue or pathogen. Once delivered to the target cell the ADC or peptide conjugate is internalized a highly toxic 2 pyrrolinodoxorubicin (2 PDox) is released intracellularly. The P2PDox peptide or ADC conjugates are of use to treat a wide variety of diseases such as cancer autoimmune disease or infectious disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充